6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effective preparation of a monoclonal antibody against human chromogranin A for immunohistochemical diagnosis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Human chromogranin A (CgA) is a ~ 49 kDa secreted protein mainly from neuroendocrine cells and endocrine cells. The CgA values in the diagnosis of tumor, and in the potential role in prognostic and predictive tumor as a biomarker.

          Results

          The synthesized gene of CgA coding area was cloned and expressed as fusion protein CgA-His in procaryotic system. Then the purified CgA-His protein was mixed with QuickAntibody-Mouse5W adjuvant, and injected into mice. The CgA-His protein was also used as coating antigen to determine the antiserum titer. By screening, a stable cell line named 4E5, which can generate anti-CgA monoclonal antibody (mAb), was obtained. The isotype of 4E5 mAb was IgG 2b, and the chromosome number was 102 ± 4. Anti-CgA mAb was purified from ascites fluid, and the affinity constant reached 9.23 × 10 9 L/mol. Furthermore, the specificity of the mAb was determined with ELISA, western blot and immunohistochemistry. Results indicated that the mAb 4E5 was able to detect chromogranin A specifically and sensitively.

          Conclusions

          A sensitive and reliable method was successfully developed for rapid production of anti-CgA mAb for immunohistochemistry diagnosis in this study, and the current study also provides conclusive guidelines for preparation of mAbs and implements in immunohistochemistry diagnosis.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Secretion of chromogranin A by peptide-producing endocrine neoplasms.

          Chromogranin A, the protein that is co-stored and co-released with catecholamines from the adrenal medulla, has recently been identified in a variety of human endocrine tissues, both normal and neoplastic. We investigated the secretion of chromogranin A by peptide hormone-producing human tumors in studies of patients with the following neoplastic disorders: pheochromocytoma, parathyroid adenoma, primary parathyroid hyperplasia, medullary thyroid carcinoma, thyroidal C-cell hyperplasia, carcinoid tumor, oat-cell lung carcinoma, pancreatic islet-cell tumor, and aortic-body tumor. All these patient groups had elevated concentrations of plasma chromogranin A. We distinguished different forms of immunoreactive plasma chromogranin A by size with the use of gel filtration. Plasma chromogranin A levels were not elevated in patients with diverse "control" conditions--both benign and malignant and both endocrine and nonendocrine--in which peptide hormones are not produced. The sensitivity and specificity of plasma chromogranin A elevations in the diagnosis of peptide-producing endocrine neoplasms were 81 and 100 percent, respectively. The elevation of plasma chromogranin A in our subjects suggests that their neoplasms co-release chromogranin A along with the usual resident hormone of the tumor, that these neoplasms could be characterized as "chromograninomas," and that measurement of plasma chromogranin A may be a useful diagnostic procedure in subjects with endocrine tumors, especially multiple endocrine neoplasia.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Monitoring dynamic expression of nuclear genes in Chlamydomonas reinhardtii by using a synthetic luciferase reporter gene

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker.

              CgA is a 49 kilodalton protein that is present in the secretory granules of most endocrine and many neuroendocrine cells. Detection of CgA in cells by immunocytochemistry and measurement of CgA in serum by immunoassay can serve as tissue and serum markers for CgA-producing tumors. CgA is of diagnostic value in classical endocrine tumors, in hormone-negative tumors, and in endocrine tumors in which other diagnostic procedures have their limitations. Although the biological function of CgA is yet unknown, it may serve as a precursor molecule, like POMC, for a family of biologically active peptides. CgA is an important new tool for the endocrinologist in the diagnosis and management of patients with endocrine and neuroendocrine tumors.
                Bookmark

                Author and article information

                Contributors
                1119383881@qq.com
                574972163@qq.com
                441512025@qq.com
                121142363@qq.com
                491585807@qq.com
                562786412@qq.com
                wshyyl@sina.com
                kjia@fafu.edu.cn
                Journal
                BMC Biotechnol
                BMC Biotechnol
                BMC Biotechnology
                BioMed Central (London )
                1472-6750
                4 May 2018
                4 May 2018
                2018
                : 18
                : 25
                Affiliations
                [1 ]ISNI 0000 0004 1760 2876, GRID grid.256111.0, Key Laboratory of Pathogenic Fungi and Mycotoxins of Fujian Province, Key Laboratory of Biopesticide and Chemical Biology of Education Ministry, and School of Life Sciences, , Fujian Agriculture and Forestry University, ; Fuzhou, 350002 China
                [2 ]Fuzhou Maixin Biotech. Co., Ltd, Fuzhou, 350100 China
                Author information
                http://orcid.org/0000-0001-5380-9370
                Article
                436
                10.1186/s12896-018-0436-z
                5935939
                29728076
                c6059949-8859-457e-858f-9c8bfdfdd227
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 25 February 2018
                : 16 April 2018
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100005270, Fujian Provincial Department of Science and Technology;
                Award ID: 2016Y0001
                Award ID: 2015J05052
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2018

                Biotechnology
                chromogranin a,monoclonal antibody,immunohistochemistry,specifility,ielisa
                Biotechnology
                chromogranin a, monoclonal antibody, immunohistochemistry, specifility, ielisa

                Comments

                Comment on this article